Gang Paul Chen - Monterey Park CA 91754 Avishay Eyal - Pasedena CA 91106 Anthony S. Kewitsch - Santa Monica CA 90402 Victor Leyva - Pasedena CA 91104 George A. Rakuljic - Santa Monica CA 90402
International Classification:
G01B 902
US Classification:
356491, 356492
Abstract:
Optical components, particularly microoptic glass components used in synthesizing birefringence in filter systems based on polarization interferometer techniques, are fabricated using systems and methods which provide accurate frequency periodicity measurements. These measurements are derived from differential delays induced by in-process glass elements between beam components in a polarization interferometer unit and from progressive wavelength scanning across a wavelength band of interest. The consequent sinusoidal output variation has peak to peak spacings which are measured to provide frequency periodicity values from which precise length corrections for the optical elements can be calculated.
Gang Chen - Walnut CA Stephanus J. Spammer - Painted Post NY
Assignee:
Corning Incorporated - Corning NY
International Classification:
G02B 628
US Classification:
385 24, 385 37, 385 46, 359130
Abstract:
One aspect of the invention is an optical add/drop multiplexer. The optical add/drop multiplexer includes a first optical circulator, the first circulator includes a first port, a second port, and a third port. The optical add/drop multiplexer also includes a first tunable grating coupled to the first port and a second tunable grating coupled to the first grating. The optical add/drop multiplexer further includes a second optical circulator, the second optical circulator includes a fourth port, coupled to the second grating; a fifth port, and a sixth port. Wherein the first tunable grating is a fiber Bragg grating and wherein the second tunable grating is a fiber Bragg grating.
Xian-Li Yeh - Walnut CA, US Gang Paul Chen - Walnut CA, US
International Classification:
H04N 595
US Classification:
385 88, 385 90, 385 91
Abstract:
Locally heated low temperature solder glass is used to permanently fix an optical fiber with sub-micron precision to a glass ceramic submount inside a high power pump laser module. The fiber is manipulated into a predetermined alignment while the solder glass is still molten and the solder glass is then cooled to its solidified state. The predetermined alignment may include an offset to compensate for subsequent thermally related dimensional changes as the solder glass cools and solidifies. If necessary, the solder glass can be remelted and the fiber realigned with a different offset if the first alignment attempt is less than optimal. This alignment process has been demonstrated to provide reliable and efficient coupling of an optical fiber to a high power pump laser within very tight tolerances. A similar process can also be applied to other micro-optics assemblies where high precision, high reliability fiber fixing is required.
Development Of Molecular Imaging Probes For Carbonic Anhydrase-Ix Using Click Chemistry
Hartmuth C. Kolb - Playa Del Rey CA, US Joseph C. Walsh - Pacific Palisades CA, US Dhanalakshmi Kasi - Los Angeles CA, US Vani P. Mocharla - Los Angeles CA, US Bing Wang - San Jose CA, US Umesh B. Gangadharmath - Los Angeles CA, US Brian A. Duclos - Kalamazoo MI, US Kai Chen - Los Angeles CA, US Wei Zhang - Los Angeles CA, US Gang Chen - Los Angeles CA, US Henry Clifton Padgett - Hermosa Beach CA, US Farhad Karimi - Canton MA, US Peter J. H. Scott - Marina-del-Ray CA, US Zhiyong Gao - Los Angeles CA, US Qianwa Liang - Hacienda Heights CA, US Thomas Lee Collier - Perkasie PA, US Tieming Zhao - Los Angeles CA, US Chunfang Xia - Los Angeles CA, US
Assignee:
Siemens Medical Solutions USA, Inc. - Malvern PA
International Classification:
A61K 51/00 C07D 343/00
US Classification:
424 111, 549 32
Abstract:
The present application discloses methods for identifying inhibitors with high binding-affinity for the carbonic anhydrase-IX (CA-IX) enzyme using click chemistry and uses the candidates thereof as positron emission tomography (PET) imaging agents.
Achievement Of A High Therapeutic Index Through Molecular Imaging Guided Targeted Drug Treatment
Hartmuth C. Kolb - Playa Del Rey CA, US Joseph C. Walsh - Pacific Palisades CA, US Kai Chen - Rockville MD, US Dhanalakshmi Kasi - Los Angeles CA, US Umesh B. Gangadharmath - Los Angeles CA, US Peter J. H. Scott - Ypsilanti MI, US Gang Chen - Los Angeles CA, US Vani P. Mocharla - Los Angeles CA, US
Assignee:
Siemens Medical Solutions USA, Inc. - Malvern PA
International Classification:
A61M 36/14 A61K 39/00
US Classification:
424 169, 4241811
Abstract:
The present disclosure provides methods for treating cancer in a patient in need of such treatment, the method includes prequalifying a patient's therapeutic treatment by performing a molecular imaging procedure to the patient using a labeled biomarker specific for a cancer target at the tumor site; and administering a therapeutic effective amount of a compound comprising a targeting agent linked to a chemotherapeutic or a targeting agent linked to an antibody. Embodiments of the present invention also include compounds and compositions for using such methods.
Imaging Agents For Detecting Neurological Dysfunction
Hartmuth C. Kolb - Playa Del Rey CA, US Joseph C. Walsh - Pacific Palisades CA, US Wei Zhang - Los Angeles CA, US Peter J. H. Scott - Marina-del-Rey CA, US Kai Chen - Los Angeles CA, US Vani P. Mocharla - Los Angeles CA, US Dhanalakshmi Kasi - Los Angeles CA, US Gang Chen - Los Angeles CA, US Eric Wang - San Diego CA, US Anjana Sinha - San Diego CA, US
Disclosed here in are compounds and methods of diagnosing Alzheimer's Disease or a predisposition thereto in a mammal, the method comprising administering to the mammal a diagnostically effective amount of a radiolabeled compound, wherein the compound is selected from the group consisting of radiolabeled flavones, coumarins, carbazoles, quinolinones, chromenones, imidazoles and triazoles derivatives, allowing the compound to distribute into the brain tissue, and imaging the brain tissue, wherein an increase in binding of the compound to the brain tissue compared to a normal control level of binding indicates that the mammal is suffering from or is at risk of developing Alzheimer's Disease.
Development Of Molecular Imaging Probes For Carbonic Anhydrase-Ix Using Click Chemistry
Hartmuth C. Kolb - Playa Del Rey CA, US Joseph C. Walsh - Pacific Palisades CA, US Dhanalakshmi Kasi - Los Angeles CA, US Vani P. Mocharla - Los Angeles CA, US Bing Wang - San Jose CA, US Umesh B. Gangadharmath - Los Angeles CA, US Brian A. Duclos - Kalamazoo MI, US Kai Chen - Rockville MD, US Wei Zhang - Norwood MA, US Gang Chen - Los Angeles CA, US Henry Clifton Padgett - Hermosa Beach CA, US Farhad Karimi - Mansfield MA, US Peter J. H. Scott - Ypsilanti MI, US Zhiyong Gao - Wynnewood PA, US Qianwa Liang - Hacienda Heights CA, US Thomas Lee Collier - Perkasie PA, US Tieming Zhao - Los Angeles CA, US Chunfang Xia - Los Angeles CA, US
The present application discloses methods for identifying inhibitors with high binding-affinity for the carbonic anhydrase-IX (CA-IX) enzyme using click chemistry and uses the candidates thereof as positron emission tomography (PET) imaging agents.
Imaging Agents Useful For Identifying Ad Pathology
Hartmuth C. Kolb - Playa Del Rey CA, US Joseph C. Walsh - Pacific Palisades CA, US Wei Zhang - Los Angeles CA, US Umesh B. Gangadharmath - Los Angeles CA, US Dhanalakshmi Kasi - Los Angeles CA, US Kai Chen - Rockville MD, US Anjana Sinha - San Diego CA, US Eric Wang - San Diego CA, US Gang Chen - Los Angeles CA, US Peter J. H. Scott - Ypsilanti MI, US Henry Clifton Padgett - Hermosa Beach CA, US Qianwa Liang - Hacienda Heights CA, US Zhiyong Gao - Wynnewood PA, US Tieming Zhao - Los Angeles CA, US Chunfang Xia - Los Angeles CA, US Vani P. Mocharla - Los Angeles CA, US
Assignee:
Siemens Medical Solutions USA, Inc. - Malvern PA
International Classification:
A61K 51/00 A61M 36/14
US Classification:
424 189, 424 111, 424 165, 424 181, 424 185
Abstract:
Provided herein are compounds and compositions which comprise the formulae as disclosed herein, wherein the compound is an amyloid binding compound. An amyloid binding compound according to the invention may be administered to a patient in amounts suitable for in vivo imaging of amyloid deposits, and distinguish between neurological tissue with amyloid deposits and normal neurological tissue. Amyloid probes of the invention may be used to detect and quantitate amyloid deposits in diseases including, for example, Down's syndrome, familial Alzheimer's Disease. In another embodiment, the compounds may be used in the treatment or prophylaxis of neurodegenerative disorders. Also provided herein are methods of allowing the compound to distribute into the brain tissue, and imaging the brain tissue, wherein an increase in binding of the compound to the brain tissue compared to a normal control level of binding indicates that the mammal is suffering from or is at risk of developing a neurodegenerative disease.
2009 to 2000 Senior Project Manager/Director of Architectural ServicePerlman Architects of California, Inc
2008 to 2009 Senior Project Manager /Vice PresidentNadel Architects, Inc
2000 to 2008 Senior Project Manager/AssociateJAG Architecture, Inc
1998 to 2000 Senior Project ManagerJeff Matzek & Associates, Inc. Costa Mesa, CA 1997 to 1998 Project ManagerGAA Architects, Inc
1995 to 1996 Job CaptainLee Burkhart Liu, Inc
1994 to 1995 Architectural Designer, HOK/LBL
Education:
University of Southern California Los Angeles, CA Jan 1993 to Jan 1994 Ph.D. in PlanningUniversity of Southern California Los Angeles, CA Jan 1990 to Jan 1993 Master's Degree in L ArchitectureSouth China University of Technology GUangzhou, Guangdong Jan 1987 to Jan 1990 Master's Degree in ArchitectureSouth China University of Technology Jan 1983 to Jan 1987 Bachelors in Architecture
Skills:
AutoCAD, Revit, Photoshop, Scribus, MS Office Software, MS Project, etc